Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P O Hedlund

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Urology|December 31, 1997
Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska seriesJ Adolfsson, G Steineck, P O Hedlund
The Journal of Urology|January 23, 1999
Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followupJ Adolfsson, G Steineck, P O Hedlund
Urologia Internationalis|January 1, 1979
Cultures from different parts of the urethra in female urethral syndromeA Obrink, G Bunne, P O Hedlund
Thrombosis Research|January 1, 1988
Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. Predictors for cardiovascular complications?M Blombäck, P O Hedlund, U Säwe
Thrombosis Research|January 1, 1988
Relationship between serum lipoproteins and hemostatic parameters in men with prostatic cancerM Blombäck, P O Hedlund, U Säwe, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1988
Modal DNA as prognostic indicator in untreated prostatic cancerP O Hedlund, J Adolfsson, L Rönström, et al.
The Journal of Urology|January 1, 1985
Treatment of prostatic cancer: effects on serum lipoproteins and the cardiovascular systemS Rössner, P O Hedlund, T Jogestrand, et al.
The Prostate|January 1, 1989
Rectal palpation and transrectal fine needle aspiration of the prostate in the monitoring of prostate cancer: a study of 59 patients during treatment with estramustine phosphate or estrogensP O Hedlund, D Das, T Löwhagen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
DNA as a prognostic marker in advanced high-grade prostatic cancer. A preliminary report. SPCG-I studyP O Hedlund, P Esposti, U Falkmer, et al.
Urological Research|January 1, 1978
Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseasesL Andersson, O Eriksson, P O Hedlund, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Urology|December 31, 1997
Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska seriesJ Adolfsson, G Steineck, P O Hedlund
The Journal of Urology|January 23, 1999
Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followupJ Adolfsson, G Steineck, P O Hedlund
Urologia Internationalis|January 1, 1979
Cultures from different parts of the urethra in female urethral syndromeA Obrink, G Bunne, P O Hedlund
Thrombosis Research|January 1, 1988
Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. Predictors for cardiovascular complications?M Blombäck, P O Hedlund, U Säwe
Thrombosis Research|January 1, 1988
Relationship between serum lipoproteins and hemostatic parameters in men with prostatic cancerM Blombäck, P O Hedlund, U Säwe, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1988
Modal DNA as prognostic indicator in untreated prostatic cancerP O Hedlund, J Adolfsson, L Rönström, et al.
The Journal of Urology|January 1, 1985
Treatment of prostatic cancer: effects on serum lipoproteins and the cardiovascular systemS Rössner, P O Hedlund, T Jogestrand, et al.
The Prostate|January 1, 1989
Rectal palpation and transrectal fine needle aspiration of the prostate in the monitoring of prostate cancer: a study of 59 patients during treatment with estramustine phosphate or estrogensP O Hedlund, D Das, T Löwhagen, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
DNA as a prognostic marker in advanced high-grade prostatic cancer. A preliminary report. SPCG-I studyP O Hedlund, P Esposti, U Falkmer, et al.
Urological Research|January 1, 1978
Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseasesL Andersson, O Eriksson, P O Hedlund, et al.
Pageof 5